IBDEI0HQ ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7720,0)
 ;;=I13.2^^63^498^46
 ;;^UTILITY(U,$J,358.3,7720,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7720,1,3,0)
 ;;=3^Hypertensive Hrt Dis & CKD V/ESRD w/ CHF
 ;;^UTILITY(U,$J,358.3,7720,1,4,0)
 ;;=4^I13.2
 ;;^UTILITY(U,$J,358.3,7720,2)
 ;;=^5007070
 ;;^UTILITY(U,$J,358.3,7721,0)
 ;;=I13.10^^63^498^49
 ;;^UTILITY(U,$J,358.3,7721,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7721,1,3,0)
 ;;=3^Hypertensive Hrt Dis & CKD w/o CHF
 ;;^UTILITY(U,$J,358.3,7721,1,4,0)
 ;;=4^I13.10
 ;;^UTILITY(U,$J,358.3,7721,2)
 ;;=^5007068
 ;;^UTILITY(U,$J,358.3,7722,0)
 ;;=I13.11^^63^498^47
 ;;^UTILITY(U,$J,358.3,7722,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7722,1,3,0)
 ;;=3^Hypertensive Hrt Dis & CKD V/ESRD w/o CHF
 ;;^UTILITY(U,$J,358.3,7722,1,4,0)
 ;;=4^I13.11
 ;;^UTILITY(U,$J,358.3,7722,2)
 ;;=^5007069
 ;;^UTILITY(U,$J,358.3,7723,0)
 ;;=I50.21^^63^498^76
 ;;^UTILITY(U,$J,358.3,7723,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7723,1,3,0)
 ;;=3^Systolic Congestive Heart Failure,Acute
 ;;^UTILITY(U,$J,358.3,7723,1,4,0)
 ;;=4^I50.21
 ;;^UTILITY(U,$J,358.3,7723,2)
 ;;=^5007240
 ;;^UTILITY(U,$J,358.3,7724,0)
 ;;=I50.22^^63^498^77
 ;;^UTILITY(U,$J,358.3,7724,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7724,1,3,0)
 ;;=3^Systolic Congestive Heart Failure,Chronic
 ;;^UTILITY(U,$J,358.3,7724,1,4,0)
 ;;=4^I50.22
 ;;^UTILITY(U,$J,358.3,7724,2)
 ;;=^5007241
 ;;^UTILITY(U,$J,358.3,7725,0)
 ;;=I20.0^^63^498^4
 ;;^UTILITY(U,$J,358.3,7725,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7725,1,3,0)
 ;;=3^Angina,Unstable
 ;;^UTILITY(U,$J,358.3,7725,1,4,0)
 ;;=4^I20.0
 ;;^UTILITY(U,$J,358.3,7725,2)
 ;;=^5007076
 ;;^UTILITY(U,$J,358.3,7726,0)
 ;;=I25.110^^63^498^7
 ;;^UTILITY(U,$J,358.3,7726,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7726,1,3,0)
 ;;=3^Athscl Hrt Disease Native Coronary Artery w/ Unstable Ang Pctrs
 ;;^UTILITY(U,$J,358.3,7726,1,4,0)
 ;;=4^I25.110
 ;;^UTILITY(U,$J,358.3,7726,2)
 ;;=^5007108
 ;;^UTILITY(U,$J,358.3,7727,0)
 ;;=I25.119^^63^498^8
 ;;^UTILITY(U,$J,358.3,7727,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7727,1,3,0)
 ;;=3^Athscl Hrt Disease Native Coronary Artery w/ Unspec Ang Pctrs
 ;;^UTILITY(U,$J,358.3,7727,1,4,0)
 ;;=4^I25.119
 ;;^UTILITY(U,$J,358.3,7727,2)
 ;;=^5007111
 ;;^UTILITY(U,$J,358.3,7728,0)
 ;;=I50.82^^63^498^26
 ;;^UTILITY(U,$J,358.3,7728,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7728,1,3,0)
 ;;=3^Biventricular Heart Failure
 ;;^UTILITY(U,$J,358.3,7728,1,4,0)
 ;;=4^I50.82
 ;;^UTILITY(U,$J,358.3,7728,2)
 ;;=^5151389
 ;;^UTILITY(U,$J,358.3,7729,0)
 ;;=I50.84^^63^498^40
 ;;^UTILITY(U,$J,358.3,7729,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7729,1,3,0)
 ;;=3^End Stage Heart Failure
 ;;^UTILITY(U,$J,358.3,7729,1,4,0)
 ;;=4^I50.84
 ;;^UTILITY(U,$J,358.3,7729,2)
 ;;=^5151391
 ;;^UTILITY(U,$J,358.3,7730,0)
 ;;=I50.83^^63^498^42
 ;;^UTILITY(U,$J,358.3,7730,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7730,1,3,0)
 ;;=3^High Output Heart Failure
 ;;^UTILITY(U,$J,358.3,7730,1,4,0)
 ;;=4^I50.83
 ;;^UTILITY(U,$J,358.3,7730,2)
 ;;=^5151390
 ;;^UTILITY(U,$J,358.3,7731,0)
 ;;=I21.A1^^63^498^56
 ;;^UTILITY(U,$J,358.3,7731,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7731,1,3,0)
 ;;=3^Myocardial Infarction Type 2
 ;;^UTILITY(U,$J,358.3,7731,1,4,0)
 ;;=4^I21.A1
 ;;^UTILITY(U,$J,358.3,7731,2)
 ;;=^5151374
 ;;^UTILITY(U,$J,358.3,7732,0)
 ;;=I50.811^^63^498^68
 ;;^UTILITY(U,$J,358.3,7732,1,0)
 ;;=^358.31IA^4^2
